rs146550489
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182919.4(TICAM1):c.557C>T(p.Ser186Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,604,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_182919.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TICAM1 | NM_182919.4 | c.557C>T | p.Ser186Leu | missense_variant | 2/2 | ENST00000248244.6 | NP_891549.1 | |
TICAM1 | NM_001385678.1 | c.515C>T | p.Ser172Leu | missense_variant | 3/3 | NP_001372607.1 | ||
TICAM1 | NM_001385679.1 | c.422C>T | p.Ser141Leu | missense_variant | 2/2 | NP_001372608.1 | ||
TICAM1 | NM_001385680.1 | c.-71-15C>T | intron_variant | NP_001372609.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TICAM1 | ENST00000248244.6 | c.557C>T | p.Ser186Leu | missense_variant | 2/2 | 1 | NM_182919.4 | ENSP00000248244.4 |
Frequencies
GnomAD3 genomes AF: 0.000592 AC: 90AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000307 AC: 74AN: 241128Hom.: 0 AF XY: 0.000268 AC XY: 35AN XY: 130816
GnomAD4 exome AF: 0.000203 AC: 295AN: 1452532Hom.: 0 Cov.: 77 AF XY: 0.000191 AC XY: 138AN XY: 722002
GnomAD4 genome AF: 0.000585 AC: 89AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74444
ClinVar
Submissions by phenotype
Herpes simplex encephalitis, susceptibility to, 4 Uncertain:2Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 07, 2022 | - - |
risk factor, no assertion criteria provided | literature only | OMIM | Dec 01, 2011 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 186 of the TICAM1 protein (p.Ser186Leu). This variant is present in population databases (rs146550489, gnomAD 0.2%). This missense change has been observed in individual(s) with herpes simplex encephalitis (PMID: 22105173). This variant is also known as TRIF. ClinVar contains an entry for this variant (Variation ID: 37266). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects TICAM1 function (PMID: 22105173). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at